{"id":"https://openalex.org/W2023720147","doi":"https://doi.org/10.4161/cbt.7.10.6834","title":"Successful treatment of relapsed lymphomatoid granulomatosis with bexarotene","display_name":"Successful treatment of relapsed lymphomatoid granulomatosis with bexarotene","publication_year":2008,"publication_date":"2008-10-01","ids":{"openalex":"https://openalex.org/W2023720147","doi":"https://doi.org/10.4161/cbt.7.10.6834","mag":"2023720147","pmid":"https://pubmed.ncbi.nlm.nih.gov/18836291"},"language":"en","primary_location":{"id":"doi:10.4161/cbt.7.10.6834","doi":"https://doi.org/10.4161/cbt.7.10.6834","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cbt.7.10.6834","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cbt.7.10.6834?needAccess=true&role=button","source":{"id":"https://openalex.org/S169029442","display_name":"Cancer Biology & Therapy","issn_l":"1538-4047","issn":["1538-4047","1555-8576"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biology & Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.4161/cbt.7.10.6834?needAccess=true&role=button","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Sigrid E. Berg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799810409","display_name":"Hospital of the University of Pennsylvania","ror":"https://ror.org/02917wp91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799810409","https://openalex.org/I4210143392"]},{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sigrid E. Berg","raw_affiliation_strings":["Abramson Cancer Center, Hospital of the University of Pennsylvania, University of Pennsylvania, Philadelphia, PA 19104, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center, Hospital of the University of Pennsylvania, University of Pennsylvania, Philadelphia, PA 19104, USA","institution_ids":["https://openalex.org/I2799810409","https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055151531","display_name":"Lisa H. Downs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa H. Downs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080030813","display_name":"Drew A. Torigian","orcid":"https://orcid.org/0000-0001-8999-9735","observed_orcids":["https://orcid.org/0000-0001-8999-9735"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Drew A. Torigian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015896987","display_name":"Elise A. Chong","orcid":"https://orcid.org/0000-0001-8895-1625","observed_orcids":["https://orcid.org/0000-0001-8895-1625"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elise A. Chong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025991750","display_name":"Donald Edward Tsai","orcid":"https://orcid.org/0000-0001-7397-5296","observed_orcids":["https://orcid.org/0000-0001-7397-5296"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Donald E. Tsai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062887811","display_name":"Mariusz A. Wasik","orcid":"https://orcid.org/0000-0002-1988-3670","observed_orcids":["https://orcid.org/0000-0002-1988-3670"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mariusz A. Wasik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5080630441","display_name":"Stephen J. Schuster","orcid":"https://orcid.org/0000-0002-3376-8978","observed_orcids":["https://orcid.org/0000-0002-3376-8978"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen J. Schuster","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2710,"currency":"EUR","value_usd":2970},"apc_paid":null,"fwci":0.176,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.61136618,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"7","issue":"10","first_page":"1544","last_page":"1546"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.8779000043869019,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.8779000043869019,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.11320000141859055,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lymphomatoid-granulomatosis","display_name":"lymphomatoid granulomatosis","score":0.9959999918937683},{"id":"https://openalex.org/keywords/bexarotene","display_name":"bexarotene","score":0.968999981880188},{"id":"https://openalex.org/keywords/relapsed-disease","display_name":"relapsed disease","score":0.7799999713897705},{"id":"https://openalex.org/keywords/retinoid-therapy","display_name":"retinoid therapy","score":0.8790000081062317},{"id":"https://openalex.org/keywords/lymphoproliferative-disorders","display_name":"lymphoproliferative disorders","score":0.9010000228881836},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.39899998903274536}],"concepts":[{"id":"https://openalex.org/C2778820923","wikidata":"https://www.wikidata.org/wiki/Q418192","display_name":"Bexarotene","level":5,"score":0.9613174200057983},{"id":"https://openalex.org/C2776135003","wikidata":"https://www.wikidata.org/wiki/Q3775784","display_name":"Lymphomatoid granulomatosis","level":3,"score":0.8523346781730652},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5606111884117126},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4384106695652008},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32541942596435547},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27528664469718933},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18654558062553406},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.160028874874115},{"id":"https://openalex.org/C63932345","wikidata":"https://www.wikidata.org/wiki/Q422500","display_name":"Nuclear receptor","level":4,"score":0.0},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077610","descriptor_name":"Bexarotene","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008230","descriptor_name":"Lymphomatoid Granulomatosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008230","descriptor_name":"Lymphomatoid Granulomatosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011239","descriptor_name":"Prednisolone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012176","descriptor_name":"Retinoids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013764","descriptor_name":"Tetrahydronaphthalenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4161/cbt.7.10.6834","doi":"https://doi.org/10.4161/cbt.7.10.6834","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cbt.7.10.6834","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cbt.7.10.6834?needAccess=true&role=button","source":{"id":"https://openalex.org/S169029442","display_name":"Cancer Biology & Therapy","issn_l":"1538-4047","issn":["1538-4047","1555-8576"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biology & Therapy","raw_type":"journal-article"},{"id":"pmid:18836291","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18836291","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer biology & therapy","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.4161/cbt.7.10.6834","doi":"https://doi.org/10.4161/cbt.7.10.6834","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cbt.7.10.6834","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cbt.7.10.6834?needAccess=true&role=button","source":{"id":"https://openalex.org/S169029442","display_name":"Cancer Biology & Therapy","issn_l":"1538-4047","issn":["1538-4047","1555-8576"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biology & Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320309370","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2023720147.pdf","grobid_xml":"https://content.openalex.org/works/W2023720147.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W88096824","https://openalex.org/W104031838","https://openalex.org/W203799104","https://openalex.org/W1973379781","https://openalex.org/W1994109490","https://openalex.org/W2022378263","https://openalex.org/W2033233777","https://openalex.org/W2050267474","https://openalex.org/W2101569211","https://openalex.org/W2115782311","https://openalex.org/W2150225212","https://openalex.org/W2171778987","https://openalex.org/W2402514173"],"related_works":["https://openalex.org/W2146092847","https://openalex.org/W2101569211","https://openalex.org/W2795333661","https://openalex.org/W2067252316","https://openalex.org/W203799104","https://openalex.org/W1998056450","https://openalex.org/W2098291983","https://openalex.org/W2090407811","https://openalex.org/W2526200685","https://openalex.org/W1938050978"],"abstract_inverted_index":{"Lymphomatoid":[0],"granulomatosis":[1,42],"is":[2,26],"a":[3,29,34,45],"rare":[4],"lymphoproliferative":[5],"disorder":[6],"involving":[7],"the":[8],"lungs,":[9],"skin":[10],"and":[11,25],"other":[12],"organs.":[13],"Advanced-stage":[14],"disease":[15],"does":[16],"not":[17],"tend":[18],"to":[19,22],"respond":[20],"well":[21],"cytotoxic":[23],"chemotherapy":[24],"associated":[27],"with":[28,43],"poor":[30],"prognosis.":[31],"We":[32],"present":[33],"case":[35],"of":[36,39],"successful":[37],"treatment":[38],"relapsed":[40],"lymphomatoid":[41],"bexarotene,":[44],"novel":[46],"retinoid":[47],"agent.":[48]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}